【结 构 式】 |
【药物名称】L-756423 【化学名称】4-(2-Benzo[b]furanyl)-N-tert-butyl-1-[2(S)-hydroxy-4(R)-[N-[2(R)-hydroxyindan-1(S)-yl]carbamoyl]-5-phenylpentyl]piperazine-2(S)-carboxamide 【CA登记号】216863-66-0 【 分 子 式 】C39H48N4O5 【 分 子 量 】652.84121 |
【开发单位】Merck & Co. (Originator) 【药理作用】AIDS Medicines, Anti-HIV Agents, ANTIINFECTIVE THERAPY, HIV Protease Inhibitors |
合成路线1
Compound (I) (intermediate no. (VIII) in scheme no. 19918301a) is a key intermediate in the synthesis of indinavir. For the synthesis of the product 285239, (I) is coupled with benzofuran-2-carbaldehyde (II) via a reductive amination by means of NaBH(OAc)3 either in 1,2-dichloroethane/AcOH or in isopropyl acetate/AcOH.
【1】 McDaniel, S.L.; McDonough, C.; Dorsey, B.D.; et al.; Identification of MK-944a: A second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitors. J Med Chem 2000, 43, 18, 3386. |
【3】 Lin, J.H.; Chodakewitz, J.A.; Deutsch, P.J.; Vacca, J.P.; Yeh, K.C.; Ju, W.D. (Merck & Co., Inc.); Combination therapy for the treatment of AIDS. WO 9925352 . |
【2】 Hoerrner, R.S.; Volante, R.P.; Purick, R.M.; Askin, D.; Reider, P.; Varsolona, R.J. (Merck & Co., Inc.); Sulfate salt of an HIV protease inhibitor having an improved oral absorption and bioavailability. EP 0986554; JP 2000513747; US 6071916; WO 9854178 . |